| A Systematic Review of Autopsy Findings in Deaths after COVID-19 Vaccination |
| A Systematic Review of COVID-19 Vaccine-Induced Takotsubo Cardiomyopathy: A 2023 Update |
| Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning |
| Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines |
| Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia |
| Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study |
| Advisory Committee on Vaccines (Australia) - Meeting 22 - Minutes on Item 2.1 - BNT162b2 [mRNA] COVID-19 vaccine |
| Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines |
| Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries |
| Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches |
| Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients |
| Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children |
| Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues |
| Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis |
| Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose |
| Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination |
| BNT162b2 Vaccine-Associated Myo/Pericarditis in Adolescents: A Stratified Risk-Benefit Analysis |
| Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting 2021-10-26 |
| Cardiac Adverse Reactions With COVID-19 Vaccinations |
| Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series |
| Cardiopulmonary Arrest After COVID-19 Vaccination: A Case Report |
| Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination |
| Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents |
| Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2 |
| Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis |
| Clinical Considerations: Myocarditis and Pericarditis after Receipt of COVID-19 Vaccines Among Adolescents and Young Adults |
| Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study |
| Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures |
| Correspondence: Myocarditis after Covid-19 mRNA Vaccination |
| COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 |
| COVID-19 Vaccination-Associated Myocarditis: A Literature Review |
| COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device |
| COVID-19 Vaccination-Related Myocarditis: What We Learned From Our Experience and What We Need to Do in The Future |
| COVID-19 Vaccine Safety Technical (VaST) Work Group |
| COVID-19 vaccine safety update: Primary series in young children and booster doses in older children and adults |
| COVID-19 Vaccine safety updates - Advisory Committee on Immunization Practices (ACIP) |
| COVID-19 vaccine weekly safety report |
| COVID-19 Vaccine-Related Myocarditis: A Descriptive Study of 40 Case Reports |
| COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals |
| Deciphering deaths associated with severe serious adverse events following SARS-CoV-2 vaccination: A retrospective cohort study |
| Delayed Vigilance: A Comment on Myocarditis in Association with the COVID-19 Injections |
| Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination |
| Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada |
| Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review |
| Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, Washington |
| Excess non-COVID-19 mortality in Norway 2020–2022 |
| Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273 |
| Heart damage from the COVID vaccines: Is it avoidable? |
| Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave |
| Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations: The role of G-quadruplexes, exosomes and microRNAs |
